| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 165,5 k € | +70.5% | 97,1 k € | +10.0% | 88,2 k € | +28.8% | 68,5 k € | +8.5% | 63,1 k € | -73.4% | 237,0 k € | +27.8% | 185,5 k € | -1.2% | 187,7 k € | -18.8% | 231,2 k € | +51.4% | 152,7 k € | -23.7% | 200,2 k € | +6.4% | 188,2 k € | -16.0% | 224,2 k € | +46.3% | 153,2 k € | -9.0% | 168,3 k € | -16.3% | 201,2 k € | +32.7% | 151,6 k € | +27.1% | 119,3 k € | |
| EBITDA | 162,5 k € | +76.4% | 92,1 k € | +6.7% | 86,3 k € | +29.2% | 66,8 k € | +8.7% | 61,4 k € | -54.4% | 134,6 k € | +1158.7% | 10,7 k € | -89.0% | 96,8 k € | -33.6% | 145,8 k € | +130.5% | 63,3 k € | -22.4% | 81,6 k € | +0.9% | 80,9 k € | -25.4% | 108,4 k € | +57.2% | 68,9 k € | -12.1% | 78,4 k € | -9.0% | 86,2 k € | +31.3% | 65,6 k € | +52.6% | 43,0 k € | |
| Operating profit | 87,9 k € | +236.2% | 26,1 k € | -37.1% | 41,6 k € | +113.1% | 19,5 k € | +43.1% | 13,6 k € | -86.5% | 100,7 k € | +838.7% | -13,6 k € | -118.2% | 75,0 k € | -38.8% | 122,5 k € | +248.1% | 35,2 k € | -13.5% | 40,7 k € | -9.2% | 44,9 k € | -31.8% | 65,8 k € | +136.9% | 27,8 k € | -25.9% | 37,5 k € | -29.5% | 53,2 k € | +47.5% | 36,0 k € | +55.9% | 23,1 k € | |
| Profit/loss | 50,1 k € | +540.9% | 7,8 k € | -63.8% | 21,6 k € | +308.3% | 5,3 k € | +5040.3% | 102,8 € | -99.9% | 70,2 k € | +359.7% | -27,0 k € | -172.7% | 37,2 k € | -44.3% | 66,7 k € | +458.6% | 11,9 k € | -16.9% | 14,4 k € | +162.1% | -23,1 k € | -120.7% | 111,9 k € | +12670.0% | 876,3 € | -83.1% | 5,2 k € | -66.8% | 15,6 k € | +703.8% | -2,6 k € | -121.9% | 11,8 k € | |
| Equity | 210,3 k € | +22.5% | 171,7 k € | +4.8% | 163,8 k € | +15.2% | 142,3 k € | +3.9% | 137,0 k € | +77.4% | 77,2 k € | +152.5% | 30,6 k € | -46.9% | 57,6 k € | +181.7% | 20,5 k € | -73.7% | 77,9 k € | +14.1% | 68,2 k € | -49.0% | 133,8 k € | -14.7% | 157,0 k € | +248.2% | 45,1 k € | +2.0% | 44,2 k € | +13.3% | 39,0 k € | +66.5% | 23,4 k € | -9.9% | 26,0 k € | |
| Total assets | 846,1 k € | -2.8% | 870,3 k € | +15.4% | 754,5 k € | +17.0% | 645,0 k € | -8.6% | 705,9 k € | +16.6% | 605,4 k € | -1.9% | 616,9 k € | +27.7% | 483,2 k € | -11.5% | 546,3 k € | -0.7% | 550,4 k € | -10.1% | 612,1 k € | -2.1% | 625,1 k € | +2.5% | 609,7 k € | +15.1% | 529,8 k € | -6.4% | 565,8 k € | -1.3% | 573,4 k € | +7.0% | 535,6 k € | +473.1% | 93,5 k € | |
| Cash | 67,3 k € | +171.3% | 24,8 k € | -38.1% | 40,1 k € | -33.4% | 60,2 k € | -34.5% | 92,0 k € | +141.3% | 38,1 k € | +197.7% | 12,8 k € | -51.6% | 26,5 k € | +52.3% | 17,4 k € | +1132.1% | 1,4 k € | +263.7% | 388,1 € | -22.8% | 502,8 € | -87.8% | 4,1 k € | -13.6% | 4,8 k € | +4.2% | 4,6 k € | +25.3% | 3,7 k € | -45.6% | 6,7 k € | +110.0% | 3,2 k € | |
| Debts | 630,9 k € | -9.0% | 693,7 k € | +18.4% | 585,6 k € | +17.7% | 497,7 k € | -11.7% | 563,9 k € | +7.8% | 523,2 k € | -10.0% | 581,3 k € | +38.2% | 420,6 k € | -19.2% | 520,8 k € | +15.6% | 450,5 k € | -14.5% | 526,9 k € | +7.3% | 490,9 k € | +8.8% | 451,1 k € | -6.2% | 481,1 k € | -6.6% | 515,1 k € | -2.9% | 530,5 k € | +4.1% | 509,6 k € | +655.8% | 67,4 k € | |
| Staff | — | — | — | — | — | — | — | 1,8 | 2,1 | 2,3 | 2,3 | 2,3 | 2,3 | 1,8 | 1,9 | 2,1 | 2 | 1,7 | ||||||||||||||||||
Private limited company · Hasselt · incorporated on 16/03/1988
Private limited company profitable and well capitalised. Cash position rising (+171.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. PEETERS KATELIJNE NEUROLOGIE is a Private limited company incorporated in 1988. Its main activity is: Specialist medical practice activities. Its registered office is in Hasselt.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette